Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Curr Opin Organ Transplant. 2021 Apr 1;26(2):153-159. doi: 10.1097/MOT.0000000000000858.
To review the impact of delayed kidney transplantation approach in combined (simultaneous) liver-kidney transplantation (CLKT).
CLKT offers a life-saving procedure for patients with both end-stage liver disease and chronic kidney disease or prolonged acute kidney injury. It is the most common multiorgan transplant procedure in the US accounting for 9-10% of all liver transplants performed. The number of CLKT has also been increasing in other countries with a better understanding of hepato-renal syndrome. US is the only country which implemented a national allocation policy for CLKT in 2017. Due to the different physiological needs of liver and kidney allografts immediately after transplantation, delayed kidney transplantation approach in CLKT has been introduced for the first time by the Indiana Group, naming it as 'the Indiana Approach'. Over the years, many other groups in the US and in Europe published better outcomes in CLKT using the delayed kidney transplantation approach with the support of hypothermic machine perfusion.
Several groups have shown that delayed kidney transplantation in CLKT is a safe procedure with better outcomes in graft(s) and patient survival.
探讨延迟肾脏移植方案在肝肾联合(同期)移植(CLKT)中的作用。
CLKT 为同时患有终末期肝病和慢性肾脏病或急性肾损伤延长的患者提供了一种挽救生命的方法。它是美国最常见的多器官移植手术,占所有进行的肝移植的 9-10%。随着对肝肾综合征认识的提高,其他国家的 CLKT 数量也在增加。美国是唯一在 2017 年为 CLKT 实施国家分配政策的国家。由于肝和肾移植物在移植后立即具有不同的生理需求,因此首次由印第安纳州小组提出了 CLKT 中的延迟肾脏移植方法,将其命名为“印第安纳方法”。多年来,美国和欧洲的许多其他小组在低温机器灌注的支持下使用延迟肾脏移植方法发表了 CLKT 更好的结果。
一些小组表明,CLKT 中的延迟肾脏移植是一种安全的手术,可改善移植物和患者的生存率。